Sanjay Shukla Net Worth & Insider Trades

Sanjay Shukla - President and CEO, Atyr Pharma Inc

As of November 21, 2022

What is Sanjay Shukla's Net Worth?

The current estimated net worth of Atyr Pharma Inc's President and CEO, Sanjay Shukla, is estimated to be about $12.9K . Sanjay Shukla owns about 50,798 units of Atyr Pharma Inc common stock. In the last 6 years at Atyr Pharma Inc, Sanjay Shukla has sold an estimated value of $8.96K worth.

What is Sanjay Shukla's Past Insider Trading?

Sanjay Shukla's largest purchase order was 15,000 units , worth over $43.16K on July 6, 2022. Sanjay Shukla's largest sale order was 778 units , worth over $5.96K on February 9, 2021. In total, Sanjay Shukla has made about 19 transactions over 6 years of their time at Atyr Pharma Inc. Sanjay Shukla usually trades in February, with the busiest year in 2021 and 2022. The most recent transaction was a purchase order of 10,000 units , worth over $21.41K on November 21, 2022.

Sanjay Shukla

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Sanjay Shukla's Salary in 2020?

As President and CEO of Atyr Pharma Inc, Sanjay Shukla has a total base salary of $470,250 . Sanjay Shukla received compensation valued at about $1,083,857 in 2020 after becoming President and CEO. The vast majority of their compensation came in the form of other earnings, plans or compensations of $223,369 , option awards of $381,811 , other earnings, plans or compensations of $223,369 , and other compensation of $8,427 .

What is Sanjay Shukla's' Mailing Address?

  • Mailing address is C/o Atyr Pharma, Inc. 3545 John Hopkins Court, Suite 250 San Diego CA 92121 CA

Atyr Pharma Inc Executive Compensation

Name
Year
Salary
Other Earnings Plans or Compensations
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Sanjay S. Shukla, M.D., M.S. 2020 $470,250 $223,369 $381,811 $223,369 $8,427 $1,083,857
Sanjay S. Shukla, M.D., M.S. 2019 $450,000 $95,625 $82,400 $95,625 $10,076 $663,961
Jill M. Broadfoot 2020 $365,750 $138,985 $182,671 $138,985 $11,374 $698,780
Jill M. Broadfoot 2019 $350,000 $59,500 $20,600 $59,500 $11,594 $454,624
Nancy E. Denyes 2020 $350,075 $116,400 $148,121 $116,400 $10,661 $625,257
Nancy E. Denyes 2019 $335,000 $49,831 $51,500 $49,831 $12,932 $449,263
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1339970/000156459021014935/life-def14a_20210428.htm

What are Atyr Pharma Inc's Past Insider Trades?

Atyr Pharma Inc's most recent insider trade came on November 21, 2022 by Sanjay Shukla who bought 10,000 units worth $21.41K . In the last 7 years, insiders at Atyr Pharma Inc have sold an estimated value of $3.13M and bought an estimated value of $16.51M worth of shares. Insider trading is most common in May, with the busiest year in 2016. The most active traders at the company are Paul Schimmel, Director,  Sanjay Shukla, President and CEO,  and John Mendlein, Director .

aTYR PHARMA INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1